Results 11 to 20 of about 3,867 (204)

„Cognitive Enhancement" or non-evidence-based nootropic abuse? – Use of Piracetam in Hungary

Cardiologia Hungarica
Piracetam has been available on the market since 1971. Its primary indication is the age-related memory decline. The objective of this review is to highlight the controversies surrounding in the use of piracetam.
András Érszegi, Máté Vámos, Réka Viola, Dezső Csupor, Anna Vágvölgyi   +4 more
doaj   +2 more sources

Synergistic neurotrophic effects of piracetam and thiotriazoline [PDF]

Неврология, нейропсихиатрия, психосоматика, 2016
The paper considers the synergy between the nootropic drug piracetam and the metabolic agent thiotriazoline that maintains energy metabolism and survival of neurons and other types of cells. Piracetam, a nootropic drug, a chemical pyrrolidone derivative,
O. A. Gromova, I. Yu. Torshin, A. V. Pronin, A. Yu. Volkov   +3 more
doaj   +2 more sources

Piracetam potentiates neuronal and behavioral effects of ketamine [PDF]

Research Results in Pharmacology, 2019
Introduction: Ketamine has a fast, but short-term antidepressant effect. To support the therapeutic effect, repeated administrations of the drug are needed, which causes cognitive disorders.
Igor I. Abramets, Yuriy V. Kuznetsov, Dmitriy V. Evdokimov, Tamara O. Zaika   +3 more
doaj   +5 more sources

Relative Efficacy of Piracetam, Modafinil and Citicoline on Cognitive Function in an Animal Model [PDF]

Journal of Clinical and Diagnostic Research, 2017
Introduction: Nootropic drugs or cognitive enhancers are pharmacological agents that improve cognitive function and memory by various mechanisms. Drugs like piracetam, modafinil and citicoline have been used as nootropic agents.
Farrukh Ahmad, Veena Nayak, Chaitanya Malalur, Rinz Mathew, Amruta Tripathy, Kurady Laxminarayana Bairy   +5 more
doaj   +2 more sources

Improved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetam

Frontiers in Neuroscience, 2010
Piracetam, the prototype of the so-called nootropic drugs’ is used since many years in different countries to treat cognitive impairment in aging and dementia.
Kristina Leuner, Christopher Kurz, Giorgio Guidetti, Jean-Marc Orgogozo, Walter E Müller   +4 more
doaj   +2 more sources

Suppression of myoclonus in SCA2 by piracetam [PDF]

Movement Disorders, 2005
AbstractWe report on a 30‐year‐old patient with advanced cerebellar degeneration due to SCA2. He presented with severe myoclonus, which was resistant to conventional therapy and dramatically improved after administration of 12–18 gm/die piracetam. Piracetam may be considered in the treatment of refractory myoclonus in spinocerebellar degenerations ...
DE ROSA, ANNA, Striano P, BARBIERI, FABRIZIO, de Falco A, Rinaldi C, Tucci T, STRIANO, SALVATORE, FILLA, ALESSANDRO, DE MICHELE, GIUSEPPE   +8 more
openaire   +6 more sources

Phytochemical Profiling and Biological Evaluation of Pistacia lentiscus L. grown in Chlef (Algeria): An Integrated In Vitro, In Vivo, and In Silico Study. [PDF]

Chem Biodivers
The antihypoxic and antioxidant activities of Pistacia lentiscus L. extract are assessed. High total phenolics and flavonoids contents are noted. Various phenolic acids and flavonoids are identified via HPLC‐MS analysis. The extract demonstrates important scavenging and reducing power, enhances mice survival under normobaric hypoxia, and reduces ...
Saiah H, Boumehira AZ, Saiah W, Boudane S, Al-Farajein A.   +4 more
europepmc   +2 more sources

Piracetam-induced neuroprotection in lipopolysaccharides-challenged EOC-20 cells and mouse brain via attenuating oxidative stress

Brazilian Journal of Pharmaceutical Sciences, 2023
Therapeutically, piracetam has been used for decades as a cognitive enhancer for memory- related neuronal disorders. The present study aimed to investigate the neuroprotective potential of piracetam on lipopolysaccharides (LPS)-induced neuronal deficit ...
Vasudevan Mani
doaj   +1 more source

Single-dose piracetam effects on global complexity measures of human spontaneous multichannel EEG [PDF]

, 1999
Global complexity of 47-channel resting electroencephalogram (EEG) of healthy young volunteers was studied after intake of a single dose of a nootropic drug (piracetam, Nootropil® UCB Pharma) in 12 healthy volunteers. Four treatment levels were used: 2.4,
Christoph M. Michel, Tanaka, Hideaki, Peuvot, Jacques, Istvan Kondakor, Hideaki Tanaka, Jiri Wackermann, Dietrich Lehmann, Jacques Peuvot, Koenig, Thomas, Lehmann, Dietrich, Michel, Christoph M., Wackermann, Jiri, Thomas Koenig, Kondakor, Istvan, Tanaka H, Peuvot J, Kondakor I, Michel CM, Wackermann J, Koenig T, Lehmann D   +20 more
core   +2 more sources

The comparison of levetiracetam and piracetam effectiveness on breath-holding spells in children: A randomized controlled clinical trial

Advanced Biomedical Research, 2021
Background: We aimed to compare the effectiveness of Levetiracetam and Piracetam on the severity and frequency of spells in children with severe breath-holding spells (BHS), i.e.
Mohammad Reza Ghazavi, Mohammad Mehdi Salehi, Jafar Nasiri, Omid Yaghini, Vahid Mansouri, Neda Hoseini   +5 more
doaj   +1 more source